CMC Considerations for CAR T Cell Product Development

The FDA's Role in Gene Therapy

74th Cellular, Tissue, and Gene Therapies Advisory Committee

The Promises and Pitfalls of Gene Therapy for Rare Diseases

MEDIA CALL: FDA Approves First Gene Therapies to Treat Sickle Cell Disease – 12/08/2023

Understanding the FDA Approval Process for Gene Therapies: Step-by-Step Explanation

An Update on the Office of Cellular, Tissue and Gene Therapies: Celia Witten, FDA

"Gene Therapy- Unlocking the Promise" Peter Marks, FDA

Regulatory considerations for Cell and Gene Therapies - Jim DeKloe

75th Cellular, Tissue, and Gene Therapies Advisory Committee

Gene Therapy Inside Out

Peter Marks on FDA Regulation of CRISPR, Gene Therapies

Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FDA Regulation of Cell and Gene Therapies: Facilitating Advanced Manufacturing

FDA Regulatory Education for Industry (REdI) – Biologics Track

Cell & gene therapies more likely to receive FDA approval: ARM Studios interview with Mark Trusheim

Are the FDA’s Gene Therapy Guidances Good for Business?

A 7-Year-Old's Blindness was Reversed by the 1st FDA-Approved Gene Therapy for Retinal Degeneration

FDA approves 'gene therapy' leukemia treatment